NEW YORK (GenomeWeb) – The University of Alabama at Birmingham School of Medicine and the HudsonAlpha Institute for Biotechnology said today they have partnered to create a new research center that will seek to accelerate genomics discoveries and move them toward clinical practice.

The plan to create the UAB-HudsonAlpha Center for Genomic Medicine was approved by the University of Alabama System Board of Trustees on June 13, and the final approval from HudsonAlpha's board of directors is expected later this summer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.